Huperzinea: Pharmacological and Therapeutic Potential
Shagun Dubey Upadhyay1★, Yusra Ahmad2, Rajesh Kumar Sharma3, Seema Kohli1★ Corresponding author
- 1Department of Pharmacy, Government Kalaniketan Polytechnic College, Jabalpur, Madhya Pradesh, INDIA.
- 2Faculty of Pharmacy, Uttarakhand Technical University, Dehradun, Uttarakhand, INDIA.
- 3College of Veterinary Science and Animal Husbandry, Nanaji Deshmukh University of Veterinary Science, Jabalpur, Madhya Pradesh, INDIA.
CORRESPONDENCE
Shagun Dubey Upadhyay
Department of Pharmacy, Government Kalaniketan Polytechnic College, Jabalpur, Madhya Pradesh, INDIA.
Volume 10, Issue 4 · pp. 146–149 · PUBLISHED · DOI: 10.5530/pc.2020.4.31
View on Pharmacogn. Commn. original site ↗
ABSTRACT
Introduction: Huperzine A (HupA) is derived from a club moss (Huperzia serrata). It is a potent and reversible inhibitor of acetyl cholinesterase (AChE). Chemically, it is a sesquiterpene alkaloid. It has been used for the treatment of swelling, fever and blood disorders for centuries in China. Methodology: The literature available on Huperzine was thoroughly studied. It has shown much beneficial effect since ages. It is a established Nootropic agent and widely used in the treatment of Alzheimer’s disease. The plant has shown promising results in vivo and in vitro studies. Results and Conclusion: The present review highlights the pharmacological potential of Huperzine with its pharmacokinetic and pharmacokinetic studies and it’s rational for future prospective.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Upadhyay, S. D., Ahmad, Y., Sharma, R. K., & Kohli, S. (). Huperzinea: Pharmacological and Therapeutic Potential. Pharmacognosy Communications, 10(4), 146–149. https://doi.org/10.5530/pc.2020.4.31